Implants for HIV prevention in young women: Provider perceptions and lessons learned from contraceptive implant provision

Preventing new HIV infections, especially amongst young women, is key to ending the HIV epidemic especially in sub-Saharan Africa. Potent antiretroviral (ARV) drugs used as pre-exposure prophylaxis (PrEP) are currently being formulated as long-acting implantable devices, or nanosuspension injectable...

Descripción completa

Detalles Bibliográficos
Autores principales: Humphries, Hilton, Upfold, Michele, Mahlase, Gethwana, Mdladla, Makhosazana, Gengiah, Tanuja N., Abdool Karim, Quarraisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758078/
https://www.ncbi.nlm.nih.gov/pubmed/35025908
http://dx.doi.org/10.1371/journal.pone.0262043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758078/
https://www.ncbi.nlm.nih.gov/pubmed/35025908
http://dx.doi.org/10.1371/journal.pone.0262043

Ejemplares similares